[ad_1]
COVAX, the World Health Organization’s COVID-19 vaccination program for poor countries, faces “very high” risk of failure and can leave states without vaccines until 2024.
This was reported by Reuters, citing internal documents from the Global Alliance for Vaccines and Immunization (GAVI). Remember Ukraine agreed with the COVAX fund in the supply of free 8 million doses of vaccine… Preliminary deliveries are expected in early 2021.
Reuters writes that COVAX is fighting lack of money, supply problems and difficult contractual relationships with drug supply companies. The fact that the program was developed in a hurry and acts on “unexplored territory“.
“The risk of failing to establish a successful COVAX center is very high.”, – read GAVI’s internal report.
In one of the November 25 memoranda included in the GAVI documents, the consultants note that higher risk because the program is linked to the provisions of the supply contracts. They allow countries not to buy vaccines reserved through COVAX.
It should be noted that this report and other documents are being discussed at a GAVI board meeting on December 15-17.
Remember:
-
COVAX is an international project that unites 189 countries.
-
It was launched by WHO in partnership with GAVI and the Coalition for Epidemic Preparedness Innovation.
-
COVAX’s goal is to deliver at least 2 billion doses of vaccines by the end of 2021 to reach the 20% of the most vulnerable in 91 low- and middle-income countries.
-
The COVAX Initiative is developing nine candidate vaccines and nine more potential vaccines are being evaluated; at the same time, negotiations are taking place with other manufacturers.
On December 12, Ukraine received official approval of the drug application from COVAX.
8 million free doses of vaccine from this fund will be enough for 4 million Ukrainians (one person must receive two injections).
The Health Ministry promised that the coronavirus vaccine will be free for Ukrainians at risk.
Coronavirus distribution map in the world:
As OBOZREVATEL reported, The Economist believes that mass access of citizens to vaccination against COVID-19 in Ukraine can be expected. not before April 2022 or 2023.
